What additional insulin can be added to Novolin 70/30 for a patient with HbA1c of 12.8?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adding Insulin to Novolin 70/30 for Better Glycemic Control

For a patient with HbA1c of 12.8% on Novolin 70/30 (60 units morning, 30 units bedtime), the most effective additional insulin regimen would be adding prandial rapid-acting insulin before meals, particularly starting with the largest meal of the day.

Understanding the Current Regimen and Need for Intensification

The patient's extremely elevated HbA1c of 12.8% indicates poor glycemic control despite being on a twice-daily premixed insulin regimen. Novolin 70/30 contains:

  • 70% intermediate-acting NPH insulin
  • 30% short-acting regular insulin

This fixed combination provides both basal and prandial coverage but clearly isn't sufficient for this patient.

Step-by-Step Approach to Intensification

1. Evaluate the Current Regimen

  • Maintain the current Novolin 70/30 doses (60 units morning, 30 units bedtime)
  • The high HbA1c suggests significant postprandial hyperglycemia that isn't adequately controlled

2. Add Prandial Insulin

  • Initial approach: Add rapid-acting insulin analog (aspart, lispro, or glulisine) before the largest meal 1
  • Starting dose: 4 units or 10% of the basal component of the current regimen 1
  • Titration: Increase by 1-2 units or 10-15% twice weekly based on postprandial glucose readings 1

3. Progressive Intensification if Needed

  • If glycemic targets aren't met, add prandial insulin before additional meals in a stepwise manner 1
  • Eventually progress to a full basal-bolus regimen if necessary

Alternative Approaches

Option 1: Convert to Basal-Bolus Regimen

If the patient has very irregular meal patterns or the above approach is insufficient:

  • Switch from Novolin 70/30 to:
    • Basal insulin (glargine, detemir, or degludec) once or twice daily
    • Rapid-acting insulin before each meal
  • This provides more flexibility but requires more injections 2

Option 2: Consider Adding a GLP-1 Receptor Agonist

  • For patients who might benefit from weight loss or have concerns about hypoglycemia
  • Can be used in combination with basal insulin 1, 2
  • Fixed-ratio combinations are available (insulin glargine/lixisenatide or insulin degludec/liraglutide) 2

Important Considerations

Hypoglycemia Risk

  • Monitor closely for hypoglycemia when adding prandial insulin
  • If hypoglycemia occurs, reduce the corresponding dose by 10-20% 1
  • Elderly patients may need more conservative targets and careful titration 1

Meal Timing and Consistency

  • Premixed insulins work best with consistent meal timing and carbohydrate content
  • Irregular meal patterns may require a more flexible insulin regimen 2

Patient Education

  • Ensure the patient understands the importance of proper timing of insulin in relation to meals
  • Teach proper injection technique and rotation of injection sites
  • Instruct on recognition and management of hypoglycemia

Monitoring and Follow-up

  • Self-monitoring of blood glucose before and 2 hours after meals
  • Adjust doses based on patterns rather than single readings
  • Consider more frequent follow-up visits during insulin intensification

By adding prandial insulin to the existing Novolin 70/30 regimen, starting with the largest meal and progressively adding to other meals if needed, the patient's glycemic control can be significantly improved while minimizing the risk of hypoglycemia.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

How do I convert insulin aspart (novolog) units to insulin regular (human insulin) units?
What medication regimen is recommended for a 21-year-old female with type 1 diabetes on Basaglar (insulin glargine) with an elevated Hemoglobin A1c (HbA1c) level?
What is the best course of treatment for a 21-year-old female patient presenting with polydipsia (excessive thirst), fatigue, and dizziness, with a hemoglobin A1c (HbA1c) level indicating hyperglycemia?
Can I introduce mealtime insulin (e.g. Novolog (insulin aspart) or Humalog (insulin lispro)) to a patient with type 2 diabetes mellitus (DM2) on Levemir (insulin detemir) 22 units daily and Metformin (metformin hydrochloride) 1000mg twice daily (BID), who was previously well controlled with a sodium-glucose cotransporter 2 (SGLT2) inhibitor but can no longer afford it?
What is the appropriate management for a 20-year-old male with increased urinary frequency, no dysuria, and a normal Hemoglobin A1c (HbA1c) level?
What is the recommended protocol for tapering off Topamax (topiramate)?
Is the Pneumococcal Conjugate (PCV) vaccine the same as the Meningococcal Conjugate (MenACWY) vaccine?
What are the treatment directions for using mupirocin (antibiotic) 2% and hydrocortisone (corticosteroid) for a skin condition, including instructions for the pharmacy on which medication to apply first?
Is aortic valve replacement (AVR) indicated in a patient with stage C1 heart failure and elevated Brain Natriuretic Peptide (BNP) levels?
What are the indications, dosing, and potential side effects of duloxetine (Cymbalta)?
What does it mean to have hypertriglyceridemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.